Tag: Prescription Drugs
AAO: Corneal Toxicity Reported With Mirvetuximab Soravtansine
Corneal toxicity not uncommon with MIRV treatment for primary gynecologic malignancies, usually resolves
People With Inflammatory Bowel Disease Face Barriers to Health Care
Barriers include access to treatment, insurance barriers, and financial issues
Annual Wasteful Spending on Lecanemab Estimated at $133 to $336 Million
Adding 75-mg vial size would achieve greatest reduction in waste, representing annual savings of $99 million
Retinal Neuroaxonal Loss Detectable With Epilepsy
People with a high number of antiseizure medications seem to be at risk for accelerated neuroaxonal loss
2013 to 2021 Saw Decline in Benzodiazepine Initiation Post-AIS
More than three-quarters of prescriptions were for a supply of more than seven days; 55 percent for 15 to 30 days
Diabetes, High BMI, Previous Metformin Common in Teens With Rx for GLP-1 RAs
Prescriptions for GLP-1 RAs less common among White teens versus Black, Hispanic teens
FDA Approves Itovebi for Locally Advanced, Metastatic Breast Cancer
Approval is for endocrine-resistant, PIK3CA-mutated, HR-positive, HER2-negative disease
Substantial Mortality Benefits Expected From Optimal Medication Use for HFrEF
1,188,277 deaths could potentially be prevented over 12 months with optimal implementation of quadruple guideline-directed medical therapy
Progression-Free Survival Improved With Nivolumab + AVD in Hodgkin Lymphoma
Longer progression-free survival seen with nivolumab + doxorubicin, vinblastine, and dacarbazine (AVD) versus brentuximab vedotin + AVD
15.5 Million Adults Had Current ADHD Diagnosis in 2023
Of the about one-third receiving stimulant medication, 71.5 percent had difficulty filling prescription due to unavailability
